VEGFA and bronchopulmonary dysplasia: Their findings demonstrate increased expression of hypoxia-inducible factors 1α and 2α (HIF1A and HIF1B, respectively), as well as VEGF and platelet-endothelial cell adhesion molecule 1 (PECAM1), and are important because they provide a potential therapeutic option for the enhancement of lung growth during BPD.